Skip to main content

Advertisement

SpringerLink
Log in

The Effect of Berberine Follow by Blue Light Irradiation and Valproic Acid on the Growth Inhibition of MDA-MB-231 Breast Cancer Cells

  • Original Article
  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Breast cancer is the second most common cancer after lung cancer in the world. Due to the anti-cancer properties of Berberine (Ber), in this study, the effect of combination therapy of Ber in the presence of blue LED irradiation and Valproic acid (Val) on the MDA-MB-231 breast cancer cell line was investigated. For this reason, after culturing the cells using different concentrations of Ber and Val, breast cancer cells were treated in both mono-treatment and combination therapy. In combination therapy, two modes were considered: (1) treatment with Val and then treatment with Ber in the dark or in presence of blue light irradiation (PDT)at a wavelength of 465 nm and energy of 30 J/cm2 for 15 min, and (2) treatment with Ber in the dark or PDT and then treated with Val. In all cases, cell viability, morphological changes, and colonization were assessed. Evaluation of apoptosis was performed by fluorescence microscope and flow cytometry. According to the results, combination therapy has a higher mortality rate compared to mono-treatment, and in combination therapy, treatment of cells first with Ber (10 µg/mL)-PDT and then treatment with Val (250 µg/mL) caused a significant reduction (P < 0/05) in the survival rate of cancer cells. According to the findings, it can be said that the use of Ber-PDT in combination with Val, in addition to reducing the dose of the drug, has shown a synergistic effect which can suggest the potential of this strategy as a new treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Raigon Ponferrada, A., Guerrero Orriach, J. L., Molina Ruiz, J. C., Romero Molina, S., Gómez Luque, A., Cruz Mañas, J. (2021). Breast cancer and anaesthesia: Genetic influence. International Journal of Molecular Sciences [Internet]. 22(14):7653. Available from: https://www.mdpi.com/1422-0067/22/14/7653

  2. Barzaman, K., Karami, J., Zarei, Z., Hosseinzadeh, A., Kazemi, M. H., Moradi-Kalbolandi, S. et al., (2020). Breast cancer: Biology, biomarkers, and treatments. International Immunopharmacology [Internet]. 84:106535. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1567576920304768

  3. Siegel, R. L., Miller, K. D., Fuchs, H. E., Jemal, A. (2021). Cancer statistics, 2021. CA: A Cancer Journal for Clinicians [Internet]. 71(1):7–33. Available from: https://onlinelibrary.wiley.com/doi/10.3322/caac.21654

  4. DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A. et al., (2019). Breast cancer statistics, 2019. CA: A Cancer Journal for Clinicians [Internet]. 69(6):438–51. Available from: https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21583

  5. Chang-Qing, Y., Jie, L., Shi-Qi, Z., Kun, Z., Zi-Qian, G., Ran, X. et al., (2020). Recent treatment progress of triple-negative breast cancer. Progress in Biophysics and Molecular Biology [Internet]. 151:40–53. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0079610719301282

  6. Garrido-Castro, A. C., Lin, N. U., Polyak, K. (2019) Insights into molecular classifications of triple-negative breast cancer: Improving patient selection for treatment. Cancer Discovery [Internet]. 9(2):176–98. Available from: http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2159-8290.CD-18-1177

  7. Won, K., & Spruck, C. (2020). Triple‑negative breast cancer therapy: Current and future perspectives (Review). International Journal of Oncology [Internet]. 57(6):1245–61. Available from: http://www.spandidos-publications.com/10.3892/ijo.2020.5135

  8. Malhotra, M. K., & Emens, L. A. (2020). The evolving management of metastatic triple-negative breast cancer. Seminars Oncology [Internet]. 47(4):229–37. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0093775420300440

  9. Bergin, A. R. T., & Loi, S. (2019). Triple-negative breast cancer: Recent treatment advances. F1000Research [Internet]. 8:1342. Available from: https://f1000research.com/articles/8-1342/v1

  10. Aumeeruddy, M. Z., & Mahomoodally, M. F. (2019). Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone. Cancer [Internet]. 125(10):1600–11. Available from: https://onlinelibrary.wiley.com/doi/10.1002/cncr.32022

  11. Lan, M., Zhao, S., Liu, W., Lee, C., Zhang, W., Wang, P. (2019). Photosensitizers for photodynamic therapy. Advanced Healthcare Materials [Internet]. 8(13):1900132. Available from: https://onlinelibrary.wiley.com/doi/10.1002/adhm.201900132

  12. Nkune, N. W., Simelane, N. W. N., Montaseri, H., Abrahamse, H. (2021). Photodynamic therapy-mediated immune responses in three-dimensional tumor models. International Journal of Molecular Sciences [Internet]. 22(23):12618. Available from: https://www.mdpi.com/1422-0067/22/23/12618

  13. Dobson, J., de Queiroz, G. F., Golding, J. P. (2018). Photodynamic therapy and diagnosis: Principles and comparative aspects. The Veterinary Journal [Internet]. 233:8–18. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1090023317302319

  14. Oh, P.-S., Hwang, H., Jeong, H.-S., Kwon, J., Kim, H.-S., Kim, M. et al., (2016). Blue light-emitting diode induces apoptosis in lymphoid cells by stimulating autophagy. The International Journal of Biochemistry & Cell Biology [Internet]. 70:13–22. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1357272515300595

  15. Yuan, Y., Yan, G., Gong, R., Zhang, L., Liu, T., Feng, C. et al., (2017). Effects of blue light emitting diode irradiation on the proliferation, apoptosis, and differentiation of bone marrow-derived mesenchymal stem cells. Cellular Physiology and Biochemistry [Internet]. 43(1):237–46. Available from: https://www.karger.com/Article/FullText/480344

  16. Zhang, Q., & Li, L. (2018). Photodynamic combinational therapy in cancer treatment. Journal of B.U.ON., 23(3), 561–567

    PubMed  Google Scholar 

  17. Loo, Y. S., Madheswaran, T., Rajendran, R., Bose, R. J. (2020). Encapsulation of berberine into liquid crystalline nanoparticles to enhance its solubility and anticancer activity in MCF7 human breast cancer cells. Journal of Drug Delivery Science and Technology [Internet]. 57:101756. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1773224720302628

  18. Kumar, A., Ekavali., Chopra, K., Mukherjee, M., Pottabathini, R., Dhull, D. K. (2015). Current knowledge and pharmacological profile of berberine: An update. European Journal of Pharmacology [Internet]. 761:288–97. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0014299915300571

  19. Zhang, C., Sheng, J., Li, G., Zhao, L., Wang, Y., Yang, W. et al., (2020). Effects of berberine and its derivatives on cancer: A systems pharmacology review. Frontiers in Pharmacology [Internet]. 10. Available from: https://www.frontiersin.org/article/10.3389/fphar.2019.01461/full

  20. Tan, W., Li, Chen, M., Wang, Y. (2011). Berberine hydrochloride: Anticancer activity and nanoparticulate delivery system. International Journal of Nanomedicine [Internet]. 1773. Available from: http://www.dovepress.com/berberine-hydrochloride-anticancer-activity-and-nanoparticulate-delive-peer-reviewed-article-IJN

  21. Cheng, L.-L., Wang, Y.-J., Huang, D.-H., Yao, S.-D., Ding, G.-J., Wang, S.-L., et al., (2014). Radiolysis and photolysis studies on active transient species of berberine. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy [Internet]. 124:670–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1386142514001061

  22. Sajadpoor, Z., Amini-Farsani, Z., Teimori, H., Shamsara, M., Sangtarash, M. H., Ghasemi-Dehkordi, P., et al., (2018) Valproic acid promotes apoptosis and cisplatin sensitivity through downregulation of H19 noncoding RNA in ovarian A2780 cells. Applied Biochemistry and Biotechnology [Internet]. 185(4):1132–44. Available from: http://link.springer.com/10.1007/s12010-017-2684-0

  23. Singh, D., Gupta, S., Verma, I., Morsy, M. A., Nair, A. B., Ahmed, A.-S. F. (2021). Hidden pharmacological activities of valproic acid: A new insight. Biomedicine & Pharmacotherapy [Internet]. 142:112021. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0753332221008040

  24. Lipska, K., Gumieniczek, A., Filip A. A. (2020). Anticonvulsant valproic acid and other short-chain fatty acids as novel anticancer therapeutics: Possibilities and challenges. Acta Pharmaceutica [Internet]. 70(3):291–301. Available from: https://www.sciendo.com/article/10.2478/acph-2020-0021

  25. Brodie, S. A., & Brandes, J. C. (2014). Could valproic acid be an effective anticancer agent? The evidence so far. Expert Review of Anticancer Therapy [Internet]. 14(10):1097–100. Available from: http://www.tandfonline.com/doi/full/10.1586/14737140.2014.940329

  26. Heers, H., Stanislaw, J., Harrelson, J., Lee, M. W. (2018). Valproic acid is an adjunctive therapeutic agent for the treatment of breast cancer. European Journal of Pharmacology [Internet]. 835:61–74. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0014299918304308

  27. Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B. et al., (2017). Combination therapy in combating cancer. Oncotarget [Internet]. 8(23):38022–43. Available from: https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.16723

  28. Hosseinzadeh, R., Khorsandi, K., Jahanshiri, M. (2017) Combination photodynamic therapy of human breast cancer using salicylic acid and methylene blue. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy [Internet]. 184:198–203. Available from: https://linkinghub.elsevier.com/retrieve/pii/S138614251730375X

  29. Yin, N., Ma, W., Pei, J., Ouyang, Q., Tang, C., Lai, L. (2014). Synergistic and antagonistic drug combinations depend on network topology. Aloy P, editor. PLoS One [Internet]. 9(4):e93960. Available from: https://dx.plos.org/10.1371/journal.pone.0093960

  30. Kasibhatla, S., Amarante-Mendes, G. P., Finucane, D., Brunner, T., Bossy-Wetzel, E., Green, D. R. (2006). Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. Cold Spring Harb Protoc [Internet]. 2006(3):pdb.prot4493. Available from: http://www.cshprotocols.org/lookup/doi/10.1101/pdb.prot4493

  31. Liang, Y., Zhang, H., Song, X., Yang, Q. (2020). Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. Seminars in Cancer Biology [Internet]. 60:14–27. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1044579X1930063X

  32. Nedeljković, M., & Damjanović, A. (2019). Mechanisms of chemotherapy resistance in triple-negative breast cancer—how we can rise to the challenge. Cells [Internet]. 22;8(9):957. Available from: https://www.mdpi.com/2073-4409/8/9/957

  33. Ibrahim, T. S., Sheha, T. A., Abo-Dya, N. E., AlAwadh, M. A., Alhakamy, N. A., Abdel-Samii, Z. K. et al., (2020). Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity. Bioorganic Chemistry [Internet]. 99:103797. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0045206819322412

  34. Zhu, M.-M., Li, H.-L., Shi, L.-H., Chen, X.-P., Luo, J., Zhang, Z.-L. (2017). The pharmacogenomics of valproic acid. Journal of Human Genetics [Internet]. 62(12):1009–14. Available from: http://www.nature.com/articles/jhg201791

  35. Mawatari, T., Ninomiya, I., Inokuchi, M., Harada, S., Hayashi, H., Oyama, K., et al., (2015). Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation. International Journal of Oncology [Internet]. 47(6):2073–81. Available from: https://www.spandidos-publications.com/10.3892/ijo.2015.3213

  36. Li, G.-F., Qian, T.-L., Li, G.-S., Yang, C.-X., Qin, M., Huang, J., et al., (2012). Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression. Genetics and Molecular Research [Internet]. 11(1):77–86. Available from: http://www.funpecrp.com.br/gmr/year2012/vol11-1/pdf/gmr1285.pdf

  37. Ozman, Z., Ozbek Iptec, B., Sahin, E., Guney Eskiler, G., Deveci Ozkan, A., Kaleli, S. (2021). Regulation of valproic acid-induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple-negative breast cancer. Molecular Biology Reports [Internet]. 48(2):1335–43. Available from: http://link.springer.com/10.1007/s11033-021-06173-8

  38. Abdelkader, N. F., Elyamany, M., Gad, A. M., Assaf, N., Fawzy, H. M., Elesawy, W. H. (2020). Ellagic acid attenuates liver toxicity induced by valproic acid in rats. Journal of Pharmacological Sciences [Internet]. 143(1):23–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1347861320300086

  39. Wawruszak, A., Halasa, M., Okon, E., Kukula-Koch, W., Stepulak, A. (2021). Valproic acid and breast cancer: State of the art in 2021. Cancers (Basel) [Internet]. 13(14):3409. Available from: https://www.mdpi.com/2072-6694/13/14/3409

  40. Aghagolzade Haji, H., Khoshbin Khoshnazar, A. R., Gharaei, R., Javan, B., Asadi, J. (2014). Effect of valproic acid and radiotherapy on the viability of MCF-7 breast cancer cell line. Journal of Gorgan University of Medical Sciences [Internet]. [cited 2022 Feb 22];16(3):49–55. Available from: http://goums.ac.ir/journal/article-1-2120-en.html

  41. Samadi, P., Sarvarian, P., Gholipour, E., Asenjan, K. S., Aghebati‐Maleki, L., Motavalli, R. et al., (2020) Berberine: A novel therapeutic strategy for cancer. IUBMB Life [Internet]. 72(10):2065–79. Available from: https://onlinelibrary.wiley.com/doi/10.1002/iub.2350

  42. Xu, J., Long, Y., Ni, L., Yuan, X., Yu, N., Wu, R. et al., (2019). Anticancer effect of berberine based on experimental animal models of various cancers: A systematic review and meta-analysis. BMC Cancer [Internet]. 19(1):589. Available from: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5791-1

  43. El Khalki, L., Maire, V., Dubois, T., Zyad, A. (2020). Berberine impairs the survival of triple negative breast cancer cells: Cellular and molecular analyses. Molecules [Internet]. 25(3):506. Available from: https://www.mdpi.com/1420-3049/25/3/506

  44. Gu, S., Song, X., Xie, R., Ouyang, C., Xie, L., Li, Q. et al., (2020). Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles. Life Science [Internet]. 257:118122. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0024320520308730

  45. Park, S. H., Sung, J. H., Kim, E. J., Chung, N. (2015). Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines. Brazilian Journal of Medical and Biological Research [Internet]. 48(2):111–9. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000200111&tlng=en

  46. Lopes, T. Z., de Moraes, F. R., Tedesco, A. C., Arni, R. K., Rahal, P., Calmon, M. F. (2020). Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells. Biomedicine & Pharmacotherapy [Internet]. 123:109794. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0753332219354162

  47. Yousefi Sadeghloo, A., Khorsandi, K., Kianmehr, Z. (2020). Synergistic effect of photodynamic treatment and doxorubicin on triple-negative breast cancer cells. Photochemical and Photobiological Sciences [Internet]. 19(11):1580–9. Available from: http://xlink.rsc.org/?DOI=D0PP00132E

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran

    Mahdieh Meschi & Zahra Kianmehr

  2. Department of Photodynamics, Medical Laser Research Center, Yara Institute, ACER, Tehran, Iran

    Khatereh Khorsandi

Authors
  1. Mahdieh Meschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khatereh Khorsandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zahra Kianmehr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Khatereh Khorsandi or Zahra Kianmehr.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meschi, M., Khorsandi, K. & Kianmehr, Z. The Effect of Berberine Follow by Blue Light Irradiation and Valproic Acid on the Growth Inhibition of MDA-MB-231 Breast Cancer Cells. Appl Biochem Biotechnol 195, 6752–6767 (2023). https://doi.org/10.1007/s12010-023-04395-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-023-04395-z

Keywords

Search

Navigation